Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Equity Ratio (2016 - 2025)

Traws Pharma (TRAW) has disclosed Equity Ratio for 14 consecutive years, with 0.06 as the latest value for Q4 2025.

  • For Q4 2025, Equity Ratio rose 95.32% year-over-year to 0.06; the TTM value through Dec 2025 reached 0.06, up 95.32%, while the annual FY2025 figure was 0.06, 95.32% up from the prior year.
  • Equity Ratio hit 0.06 in Q4 2025 for Traws Pharma, down from 0.37 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.83 in Q4 2021 and bottomed at 5.65 in Q2 2024.
  • Average Equity Ratio over 5 years is 0.14, with a median of 0.58 recorded in 2023.
  • Year-over-year, Equity Ratio plummeted 1010.43% in 2024 and then surged 260.55% in 2025.
  • Traws Pharma's Equity Ratio stood at 0.83 in 2021, then dropped by 13.51% to 0.72 in 2022, then tumbled by 34.57% to 0.47 in 2023, then plummeted by 369.32% to 1.27 in 2024, then soared by 95.32% to 0.06 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.06, 0.37, and 0.53 for Q4 2025, Q3 2025, and Q2 2025 respectively.